NO178696C - Akridinforbindelse og farmasöytisk preparat inneholdende denne - Google Patents
Akridinforbindelse og farmasöytisk preparat inneholdende denneInfo
- Publication number
- NO178696C NO178696C NO924066A NO924066A NO178696C NO 178696 C NO178696 C NO 178696C NO 924066 A NO924066 A NO 924066A NO 924066 A NO924066 A NO 924066A NO 178696 C NO178696 C NO 178696C
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical composition
- composition containing
- compound
- acridine compound
- acridine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- C07D219/06—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919122305A GB9122305D0 (en) | 1991-10-21 | 1991-10-21 | Therapeutic agents |
| GB929213538A GB9213538D0 (en) | 1992-06-25 | 1992-06-25 | Therapeutic agent |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO924066D0 NO924066D0 (no) | 1992-10-20 |
| NO924066L NO924066L (no) | 1993-04-22 |
| NO178696B NO178696B (no) | 1996-02-05 |
| NO178696C true NO178696C (no) | 1996-05-15 |
Family
ID=26299722
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO924066A NO178696C (no) | 1991-10-21 | 1992-10-20 | Akridinforbindelse og farmasöytisk preparat inneholdende denne |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5258390A (de) |
| EP (1) | EP0539153B1 (de) |
| JP (1) | JP3157924B2 (de) |
| KR (1) | KR930007907A (de) |
| AT (1) | ATE152103T1 (de) |
| AU (1) | AU659500B2 (de) |
| CA (1) | CA2080950A1 (de) |
| CZ (1) | CZ317592A3 (de) |
| DE (2) | DE69223736T2 (de) |
| FI (1) | FI924744L (de) |
| GB (1) | GB9220570D0 (de) |
| HU (1) | HUT65626A (de) |
| IL (1) | IL103478A0 (de) |
| MY (1) | MY106661A (de) |
| NO (1) | NO178696C (de) |
| NZ (1) | NZ244822A (de) |
| PL (1) | PL169716B1 (de) |
| TW (1) | TW223061B (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9214120D0 (en) * | 1991-07-25 | 1992-08-12 | Ici Plc | Therapeutic amides |
| CA2080949A1 (en) * | 1991-10-21 | 1993-04-22 | Cyrus John Ohnmacht | Therapeutic agents |
| US5455253A (en) * | 1992-10-20 | 1995-10-03 | Zeneca Limited | Heterocyclic derivatives |
| GB9318935D0 (en) * | 1992-10-20 | 1993-10-27 | Zeneca Ltd | Heterocyclic derivatives |
| GB9310069D0 (en) * | 1993-05-17 | 1993-06-30 | Zeneca Ltd | Heterocyclic compounds |
| GB9407432D0 (en) * | 1994-04-14 | 1994-06-08 | Zeneca Ltd | Heterocyclic derivative |
| EP0820288B1 (de) | 1995-03-03 | 2004-02-11 | Endo Pharmaceuticals Inc. | Verwendung von dextromethorphan oder dextrorphan zur behandlung der harninkontinenz |
| GB9707695D0 (en) * | 1996-08-07 | 1997-06-04 | Hoffmann La Roche | Tricyclic dione derivatives |
| US7030096B1 (en) * | 1997-02-13 | 2006-04-18 | Albert Einstein College Of Medicine Of Yeshiva University | Method of enhancing relaxation of penile smooth muscle by introduction of DNA encoding maxi-K potassium channel protein |
| US6642222B2 (en) | 1998-10-28 | 2003-11-04 | Abbott Laboratories | Pyrano, piperidino, and thiopyrano compounds and methods of use |
| AU1459500A (en) * | 1998-10-28 | 2000-05-15 | Abbott Laboratories | Dihydropyridine compounds and methods of use |
| US6191140B1 (en) * | 1998-10-28 | 2001-02-20 | Abbott Laboratories | Pyrano, piperidino, and thiopyrano compounds and methods of use |
| US6518279B2 (en) | 1999-03-04 | 2003-02-11 | Abbott Laboratories | Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| TWI287984B (en) * | 2000-10-17 | 2007-10-11 | Wyeth Corp | Pharmaceutical composition for modulating bladder function |
| AR033095A1 (es) | 2001-04-04 | 2003-12-03 | Wyeth Corp | Metodos para el tratamiento de motilidad gastrica hiperactiva |
| EP1688141A1 (de) | 2005-01-31 | 2006-08-09 | elbion AG | Verwendung von Flupirtine zur Behandlung der hyperaktiven Blase und damit zusammenhängender Erkrankungen und zur Behandlung des Reizdarmsyndroms |
| EP1896112A4 (de) * | 2005-06-07 | 2011-04-27 | A M S Res Corp | Injektionsführsystem und verfahren |
| DE602007003697D1 (de) | 2006-02-10 | 2010-01-21 | Janssen Pharmaceutica Nv | Ffner |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3454577A (en) * | 1965-11-09 | 1969-07-08 | Hoffmann La Roche | 4-(1,2,3,4,5,6,7,8 - octahydro - 1,8 - dioxo-9-acridanyl) - benzenesulfonamide and derivatives |
| DE2003148A1 (de) * | 1970-01-24 | 1971-07-29 | Bayer Ag | Neue 1,4-Dihydropyridinderivate |
| DE2018738A1 (en) * | 1970-04-18 | 1971-10-28 | Farbenfabriken Bayer Ag, 5090 Leverkusen | Hydrogenated pyridines, quinolines andacridi |
| US4021434A (en) * | 1972-01-22 | 1977-05-03 | Yamanouchi Pharmaceutical Co., Ltd. | Sodium β-[2,6-dimethyl-3,5-bis(ethoxycarbonyl)-4-(3-nitrophenyl)-1,4-dihydropyridine-1-yl]ethyl sulfate |
| DE2242106A1 (de) * | 1972-08-26 | 1974-03-21 | Agfa Gevaert Ag | Lichtempfindliches photographisches material |
| DE2718130C2 (de) * | 1977-04-23 | 1979-05-17 | Du Pont De Nemours (Deutschland) Gmbh, 4000 Duesseldorf | lichtempfindliches Aufzeichnungsmaterial |
| US4546186A (en) * | 1983-12-14 | 1985-10-08 | American Home Products Corporation | 1,4,5,6,7,8-Hexahydro-2-methyl-5-oxo-4-(2-thiazolyl)-3-quinoline carboxylic acid 2-methyl(phenylmethyl)amino ethyl ester and pharmaceutically acceptable salts |
-
1992
- 1992-09-30 GB GB929220570A patent/GB9220570D0/en active Pending
- 1992-10-20 DE DE69223736T patent/DE69223736T2/de not_active Expired - Fee Related
- 1992-10-20 NZ NZ244822A patent/NZ244822A/en unknown
- 1992-10-20 CA CA002080950A patent/CA2080950A1/en not_active Abandoned
- 1992-10-20 DE DE69219271T patent/DE69219271T2/de not_active Expired - Fee Related
- 1992-10-20 KR KR1019920019226A patent/KR930007907A/ko not_active Withdrawn
- 1992-10-20 EP EP92309566A patent/EP0539153B1/de not_active Expired - Lifetime
- 1992-10-20 NO NO924066A patent/NO178696C/no unknown
- 1992-10-20 TW TW081108329A patent/TW223061B/zh active
- 1992-10-20 PL PL92296229A patent/PL169716B1/pl unknown
- 1992-10-20 AU AU27139/92A patent/AU659500B2/en not_active Ceased
- 1992-10-20 JP JP28186292A patent/JP3157924B2/ja not_active Expired - Fee Related
- 1992-10-20 FI FI924744A patent/FI924744L/fi not_active Application Discontinuation
- 1992-10-20 US US07/963,798 patent/US5258390A/en not_active Expired - Lifetime
- 1992-10-20 MY MYPI92001895A patent/MY106661A/en unknown
- 1992-10-20 IL IL92103478A patent/IL103478A0/xx unknown
- 1992-10-20 AT AT92309566T patent/ATE152103T1/de not_active IP Right Cessation
- 1992-10-20 HU HU9203288A patent/HUT65626A/hu unknown
- 1992-10-20 CZ CS923175A patent/CZ317592A3/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2713992A (en) | 1993-04-22 |
| CA2080950A1 (en) | 1993-04-22 |
| EP0539153B1 (de) | 1997-04-23 |
| DE69219271T2 (de) | 1997-08-07 |
| KR930007907A (ko) | 1993-05-20 |
| AU659500B2 (en) | 1995-05-18 |
| HUT65626A (en) | 1994-07-28 |
| PL296229A1 (en) | 1993-10-04 |
| NO178696B (no) | 1996-02-05 |
| GB9220570D0 (en) | 1992-11-11 |
| DE69223736T2 (de) | 1998-05-07 |
| EP0539153A1 (de) | 1993-04-28 |
| DE69223736D1 (de) | 1998-02-05 |
| JP3157924B2 (ja) | 2001-04-23 |
| HU9203288D0 (en) | 1992-12-28 |
| TW223061B (en) | 1994-05-01 |
| PL169716B1 (pl) | 1996-08-30 |
| ATE152103T1 (de) | 1997-05-15 |
| NO924066L (no) | 1993-04-22 |
| MY106661A (en) | 1995-07-31 |
| FI924744A0 (fi) | 1992-10-20 |
| CZ317592A3 (en) | 1993-05-12 |
| US5258390A (en) | 1993-11-02 |
| NZ244822A (en) | 1994-10-26 |
| NO924066D0 (no) | 1992-10-20 |
| FI924744A7 (fi) | 1993-04-22 |
| FI924744L (fi) | 1993-04-22 |
| IL103478A0 (en) | 1993-03-15 |
| DE69219271D1 (de) | 1997-05-28 |
| JPH05201986A (ja) | 1993-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI924744A0 (fi) | Terapeutiska aemnen | |
| MY103352A (en) | Piperazinyl-heterocyclic compounds | |
| ITFI930247A1 (it) | Antagonisti delle tachichinine,procedimento per la loro preparazione e loro impiego in formulazioni farmaceutiche. | |
| NZ247201A (en) | Substituted sulphonylamido- or sulphonamidocarbonyl-pyridine-2-carboxamide derivatives and pharmaceutical compositions | |
| TW273550B (de) | ||
| ES8603870A1 (es) | Un procedimiento para la preparacion de derivados de 2,2'-iminobisetanol. | |
| WO2003000695A8 (en) | Pyrrolopyrimidines as protein kinase inhibitors | |
| ATE248837T1 (de) | Chinuclidin-acrylamide | |
| ATE153853T1 (de) | Stabile, orale und absorbierbare therapeutische zusammensetzungen von nadh und nadph | |
| KR900011755A (ko) | 2-아미노피리미딘온 유도체 | |
| CA2163361A1 (en) | Therapeutic substituted guanidines | |
| ATE321543T1 (de) | Pharmazeutische zusammensetzungen mit hydroximsäurederivaten | |
| NO933524L (no) | Krystallisk tiagabinhydrokloridmonohydrat samt fremstilling og anvendelse derav | |
| DE68922537D1 (de) | Antipsychotische 3-Piperazinylbenzazolderivate. | |
| ATE161531T1 (de) | Acridine-1,8-dionderivate als therapeutisches mittel | |
| MD1560F2 (en) | Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses. | |
| MY103210A (en) | Arylpiperazinyl-alkylene-phenyl-heterocyclic compounds. | |
| DK0610078T3 (da) | Cytotoksisk og antiviral forbindelse. | |
| NO941514L (no) | Kondenserte kinolyl-dihydropyridiner, deres fremstilling og anvendelse | |
| EP0302757A3 (de) | Antiemetisch wirksame Serotonin-Depletoren | |
| ZA933455B (en) | Thiochroman compounds, processes for the preparation thereof and pharmaceutical compositions containing them | |
| GR3025797T3 (en) | New carboxylic-acid esters of 2-amino-7-(1,3-dihydroxy-2-propoxymethyl)purine, the preparation of such esters and their use | |
| DE59101818D1 (de) | Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung. | |
| NZ223333A (en) | 3-phenyl-7h-thiazole (3,2-b (1,2, triazin-7-one derivatives and pharmaceutical compositions | |
| MX9205778A (es) | Agente terapeutico. |